Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Ophthalmology · JIA-Associated Uveitis

How Often Do Kids With JIA Need Uveitis Eye Exams?

At a Glance

Children with JIA need a specialized slit-lamp eye exam every 3, 6, or 12 months to check for silent eye inflammation called uveitis. The exact screening schedule depends on a child's specific risk factors, including their ANA status, JIA subtype, and age of diagnosis.

Children diagnosed with juvenile idiopathic arthritis (JIA) must have their first specialized eye exam immediately upon suspected or confirmed diagnosis [1]. After this initial visit, the ongoing screening schedule is determined by guidelines from the American College of Rheumatology (ACR) and the American Academy of Ophthalmology (AAO). Rather than a “one-size-fits-all” approach, your child will need an exam every 3, 6, or 12 months based entirely on their specific medical risk factors [2][3].

The General Screening Schedule

Ophthalmologists and rheumatologists calculate your child’s risk for developing uveitis (eye inflammation) by combining four variables: ANA status, age of JIA onset, time since diagnosis, and JIA subtype [4][5].

Based on the ACR screening guidelines, here is what you can generally expect:

  • Every 3 Months (High Risk): Children diagnosed at a young age (under 7 years old) who are ANA-positive and are in the first 4 to 5 years of their disease [6][4].
  • Every 6 Months (Moderate Risk): Children who have a mix of risk factors. This includes those who are ANA-positive but were diagnosed older than 7, or those who are ANA-negative but were diagnosed at a very young age [2][7].
  • Every 12 Months (Low Risk): Children who are ANA-negative and were older than 7 at diagnosis, or children who have systemic JIA, which rarely involves this type of eye inflammation [8][2].

As your child moves further past the 4-to-5 year mark from their initial diagnosis, their risk generally decreases, and their eye doctor may space their appointments out further [6][1]. Additionally, if your child’s JIA is well-controlled on specific systemic medications like methotrexate or biologic drugs (such as TNF inhibitors), the ophthalmologist may recommend less frequent visits [9][10].

Understanding the Four Risk Factors

  • ANA Positivity: The most significant predictor of uveitis is whether your child’s blood tests positive for Antinuclear Antibodies (ANA). An ANA-positive result dramatically increases the risk of eye inflammation [11][4].
  • Age of Onset: Children diagnosed with JIA before turning 7 years old have a higher risk than those diagnosed later in childhood [4].
  • Disease Duration: The vast majority of uveitis cases appear in the first 4 years following a JIA diagnosis, which is why screening is most intensive during these initial years [12].
  • JIA Subtype: Children with oligoarticular JIA (affecting 4 or fewer joints) and polyarticular JIA have the highest rates of uveitis [4].

What is a Slit-Lamp Exam?

JIA-associated uveitis is notoriously “silent.” In its early stages, it typically causes no redness, no pain, and no blurry vision [13][14]. By the time a child actually notices a vision problem, irreversible damage such as cataracts or glaucoma may have already occurred [15].

Because this inflammation is invisible to the naked eye, a standard vision test at school or a routine pediatrician visit cannot detect it [16]. Pediatricians use standard ophthalmoscopes to look at the back of the eye, but JIA-uveitis happens in the front part of the eye (the anterior chamber).

To detect this silent inflammation, you must see an ophthalmologist (ideally a pediatric ophthalmologist) who will perform a slit-lamp exam [17]. A slit lamp is a specialized, high-magnification microscope equipped with a bright, focused beam of light. This machine allows the eye doctor to look directly into the fluid of the anterior chamber of the eye to search for microscopic white blood cells and flare (protein leakage from blood vessels) [18][19]. Finding these microscopic cells is the only way to catch JIA-uveitis early, long before it affects your child’s vision [17].

Important Safety Note: While the most common forms of JIA-uveitis (in oligoarticular and polyarticular JIA) are completely silent, certain other subtypes—like Enthesitis-Related Arthritis (ERA) or Juvenile Psoriatic Arthritis—can cause acute, highly symptomatic eye inflammation. If your child’s eye ever becomes red, painful, or extremely sensitive to light, do not wait for your next scheduled screening. Seek emergency eye care immediately.

Common questions in this guide

Why does my child with JIA need a special eye exam if they see fine?
JIA-associated uveitis is typically silent in its early stages, meaning it causes no redness, pain, or blurry vision. Standard school vision tests cannot detect this inflammation. It must be found early using a slit-lamp exam to prevent irreversible damage like cataracts or glaucoma.
What is the eye exam schedule for a child with JIA?
The screening schedule is every 3, 6, or 12 months depending on your child's specific risk factors. High-risk children, such as those diagnosed young or who test positive for ANA, need exams every 3 months. Lower-risk children may only need an exam once a year.
What makes a child with JIA high risk for uveitis?
The most significant risk factor for uveitis is testing positive for Antinuclear Antibodies (ANA). Other high-risk factors include being diagnosed with JIA before age 7, having the oligoarticular or polyarticular subtypes, and being within the first four to five years of diagnosis.
What is a slit-lamp exam?
A slit-lamp is a specialized, high-magnification microscope with a bright, focused beam of light. It allows an ophthalmologist to look directly into the front part of the eye to find microscopic white blood cells and protein leakage, which is the only way to catch JIA-uveitis early.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my child ANA positive or negative?
  2. 2.Based on my child's age of onset, JIA subtype, and ANA status, what is their specific ACR risk category for uveitis (high, moderate, or low)?
  3. 3.Based on these risk factors, should we currently be on a 3, 6, or 12-month screening rotation for slit-lamp exams?
  4. 4.Do any of the systemic medications my child is currently taking, like methotrexate or biologics, lower their risk of uveitis?
  5. 5.Do you have a specific pediatric ophthalmologist you recommend who is experienced in performing slit-lamp exams on young children?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Does My Child With JIA Need a 504 Plan for School?Can a Child Have JIA With Normal Blood Test Results?Can Kids with Juvenile Idiopathic Arthritis Play Sports?Is it Growing Pains or JIA? How to Tell the DifferenceDo Children Outgrow Juvenile Idiopathic Arthritis?Does Diet Help Treat Juvenile Idiopathic Arthritis?Should My Child Start Biologics Right Away for JIA?Is It JIA or Lyme Disease? How to Tell the DifferenceIs Juvenile Idiopathic Arthritis (JIA) Hereditary?Are Biologics Safe for JIA? Long-Term Cancer RisksCan Psoriatic JIA Occur Without a Rash?What Are the Emergency Signs of MAS in sJIA Children?Why Does My Child Need a TMJ MRI for JIA?Which Vaccines Are Safe for Kids on JIA Biologics?

References

References (19)
  1. 1

    Uveitis in Juvenile Idiopathic Arthritis: 18-Year Outcome in the Population-based Nordic Cohort Study.

    Rypdal V, Glerup M, Songstad NT, et al.

    Ophthalmology 2021; (128(4)):598-608 doi:10.1016/j.ophtha.2020.08.024.

    PMID: 32866542
  2. 2

    2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.

    Angeles-Han ST, Ringold S, Beukelman T, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2019; (71(6)):864-877 doi:10.1002/art.40885.

    PMID: 31021511
  3. 3

    2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.

    Angeles-Han ST, Ringold S, Beukelman T, et al.

    Arthritis care & research 2019; (71(6)):703-716 doi:10.1002/acr.23871.

    PMID: 31021540
  4. 4

    Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort.

    Lee JJY, Duffy CM, Guzman J, et al.

    Arthritis care & research 2019; (71(11)):1436-1443 doi:10.1002/acr.23783.

    PMID: 30320957
  5. 5

    Juvenile Idiopathic Arthritis-Associated Chronic Uveitis: Recent Therapeutic Approaches.

    Quartier P

    Journal of clinical medicine 2021; (10(13)) doi:10.3390/jcm10132934.

    PMID: 34208973
  6. 6

    Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.

    Papadopoulou M, Zetterberg M, Oskarsdottir S, Andersson Grönlund M

    Acta ophthalmologica 2017; (95(7)):741-747 doi:10.1111/aos.13388.

    PMID: 28205413
  7. 7

    Diagnosis and treatment of uveitis associated with juvenile idiopathic arthritis.

    Lazăr C, Spîrchez M, Ştefan M, et al.

    Medicine and pharmacy reports 2021; (94(Suppl No 1)):S28-S32 doi:10.15386/mpr-2224.

    PMID: 34527905
  8. 8

    Juvenile Idiopathic Arthritis.

    Barut K, Adrovic A, Şahin S, Kasapçopur Ö

    Balkan medical journal 2017; (34(2)):90-101 doi:10.4274/balkanmedj.2017.0111.

    PMID: 28418334
  9. 9

    Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.

    Tappeiner C, Schenck S, Niewerth M, et al.

    Arthritis care & research 2016; (68(1)):46-54 doi:10.1002/acr.22649.

    PMID: 26212111
  10. 10

    A Nordic screening guideline for juvenile idiopathic arthritis-related uveitis.

    Leinonen S

    Acta ophthalmologica 2023; (101(4)):465-468 doi:10.1111/aos.15299.

    PMID: 36458735
  11. 11

    Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study.

    Nordal E, Rypdal V, Christoffersen T, et al.

    Pediatric rheumatology online journal 2017; (15(1)):66 doi:10.1186/s12969-017-0195-8.

    PMID: 28821293
  12. 12

    Clinical Characteristics and Prognosis of Juvenile Idiopathic Arthritis-Associated Uveitis: A Single-Center Retrospective Study.

    Li L, Zhang JM, Deng JH, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2025; (19()):2813-2820 doi:10.2147/OPTH.S529421.

    PMID: 40861327
  13. 13

    Uveitis in juvenile idiopathic arthritis.

    Petty RE, Zheng Q

    World journal of pediatrics : WJP 2020; (16(6)):562-565 doi:10.1007/s12519-019-00331-6.

    PMID: 31965444
  14. 14

    A practical approach to uveitis screening in children with juvenile idiopathic arthritis.

    Foeldvari I, Bohn M, Petrushkin H, et al.

    The British journal of ophthalmology 2025; (109(3)):372-376 doi:10.1136/bjo-2023-324406.

    PMID: 38575198
  15. 15

    Juvenile idiopathic arthritis-associated uveitis.

    Sen ES, Ramanan AV

    Best practice & research. Clinical rheumatology 2017; (31(4)):517-534 doi:10.1016/j.berh.2018.01.002.

    PMID: 29773271
  16. 16

    UVESCREEN1: A randomised feasibility study of imaging-based uveitis screening for children with juvenile idiopathic arthritis- Study Protocol.

    Dave S, Rahi JS, Petrushkin H, et al.

    PloS one 2025; (20(2)):e0316410 doi:10.1371/journal.pone.0316410.

    PMID: 39937818
  17. 17

    [Diagnostic Approaches to the Cornea (Part 1) - Anatomical Fundamentals and Standard Methods].

    Kaiser KP, Shajari M, Daas L, Kohnen T

    Klinische Monatsblatter fur Augenheilkunde 2026; (243(5)):619-634 doi:10.1055/a-2572-4631.

    PMID: 41702554
  18. 18

    Oral phospholipidic curcumin in juvenile idiopathic arthritis-associated uveitis.

    Miserocchi E, Giuffrè C, Cicinelli MV, et al.

    European journal of ophthalmology 2020; (30(6)):1390-1396 doi:10.1177/1120672119892804.

    PMID: 31801359
  19. 19

    Laser flare photometry in uveitis.

    Kesim C, Chehab Z, Hasanreisoglu M

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2022; (36(4)):337-343 doi:10.4103/sjopt.sjopt_119_22.

    PMID: 36618569

This page is for informational purposes only and does not replace professional medical advice. Always consult your child's rheumatologist and ophthalmologist regarding their specific uveitis screening schedule.

Get notified when new evidence is published on Juvenile idiopathic arthritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.